Worth Venture Partners, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2020$358,000
+188.7%
85,425
+171.2%
0.22%
+260.7%
Q4 2019$124,000
-71.4%
31,498
-36.1%
0.06%
-75.3%
Q3 2019$434,000
+112.7%
49,300
+124.1%
0.25%
+118.6%
Q2 2019$204,000
-66.8%
22,000
-77.0%
0.11%
-67.1%
Q1 2019$615,00095,6070.34%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,138,893$123,256,00018.11%
Broadfin Capital, LLC 1,656,720$49,337,0007.69%
SECTORAL ASSET MANAGEMENT INC 1,128,219$33,598,0003.68%
Perceptive Advisors 4,313,611$128,459,0003.60%
RTW INVESTMENTS, LP 1,122,540$33,429,0003.18%
Asymmetry Capital Management, L.P. 55,864$1,664,0002.08%
EMORY UNIVERSITY 77,335$2,303,0001.64%
Monashee Investment Management LLC 185,000$5,509,0001.52%
SPHERA FUNDS MANAGEMENT LTD. 260,000$7,743,0001.18%
Stanley-Laman Group, Ltd. 167,825$4,998,0001.14%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders